FDA Approves Pfizer, Moderna’s Newly Formulated COVID Vaccines That Specifically Address Omicron Variant

Medicine & Technology Sep 12, 2023

FDA gave a green light to Pfizer and Moderna's newly formulated vaccine against COVID that specifically targets the omicron variant XBB.1.5. Continue reading to learn more.

WHO Warns: Omicron Subvariant XBB.1.5 Evades Antibodies From Vaccines and Infection; Most Transmissible COVID-19 Variant Yet

Jan 05, 2023

The World Health Organization (WHO) declares the Omicron subvariant XBB.1.5 as the most transmissible COVID-19 variant after accounting for 41% of the cases in the country. Read the article to learn more.

New Omicron Variant Now Accounts for 41% of All COVID-19 Cases in the US Just in Time for the New Year

Jan 01, 2023

The most recent data from the CDC reveals that a new Omicron variant has taken hold in the US, raising concerns about another potential COVID-19 wave. Read the article to learn more details.